Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer (ACCRAPAN)

NCT04016142 PHASE2 TERMINATED

This is a mutlicentric, open-label non-randomized, national, 2-stage phase II trial to assess efficacy and safety of a weekly Carboplatin-Paclitaxel adjuvant chemotherapy after intensity modulated extended-field chemoradiation in patient suffering from of locally advanced cervical cancer with para-aortic positive nodes.

Details

Lead sponsor	Centre Oscar Lambret
Phase	PHASE2
Status	TERMINATED
Enrolment	21
Start date	Wed Jul 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jan 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Locally Advanced Cancer
• Cervical Cancer

Interventions

• Carboplatin-Paclitaxel adjuvant chemotherapy

Countries

France